Anacor Pharma (ANAC) Tops Q4 EPS by 37c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. SPY
10. MRVL

Go back to Anacor Pharma (ANAC) Tops Q4 EPS by 37c

Anacor Pharmaceuticals Announces Presentations at the American Academy of Dermatology Annual Meeting

March 12, 2015 4:02 PM EDT

PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced that the following abstracts have been accepted for presentation at the upcoming 73rd Annual Meeting of the American Academy of Dermatology to be held in San Francisco, California March 20 to 24, 2015:

AN2728, an investigational non-steroidal topical PDE-4 inhibitor for the potential treatment of mild-to-moderate atopic dermatitis in children and adults "Maximal Use Systemic Exposure (MUSE) Study Evaluating AN2728, A Novel Boron-Based Small Molecule, for the Treatment of Pediatric and Adolescent Subjects with Mild-to-Moderate... More